Sign in / Join Now
ETFs & Funds
well positioned, earnings Monday, sales of nd Erivedge a potential catalyst, then good chance of EMA/CHMP approval in 2 weeks!
Add a reply...
Latest StockTalks »
people get CRIS breaking news and analysis by email alert.
Get email alerts on CRIS »
Get latest price
From other sites
Curis (CRIS) Worth Watching: Stock Moves Up 5.7% - Tale of the Tape
at Zacks.com (Jun 29, 2015)
Curis Reports Dosing of First Patient in Phase 1 Trial of CUDC-907 in Patients with Advanced/Relapsed Solid Tumors
at Benzinga.com (Dec 18, 2014)
Midday Movers: Amgen, Biogen, Priceline & More
at CNBC.com (Mar 31, 2014)
Midday movers: Telsa Motors,Ralph Lauren, Microsoft & more
at CNBC.com (Nov 6, 2013)
Curis to Release Second Quarter 2013 Financial Results and Hold Conference Call on August 5, 2013
at CNBC.com (Jul 29, 2013)